Efficacy and safety of switching suppressed patients with elevated triglycerides from lopinavir/ritonavir or fosamprenavir/ritonavir to atazanavir/ritonavir or darunavir/ritonavir based therapy: The LARD study

✍ Scribed by Daniel J. Skiest; Calvin Cohen; Homayoon Khanlou; Edwin DeJesus; Thanes Vanig; Marc Tribble; Andrew Petroll; Hannah Olivet; Karam Mounzer; Robert Corales; Frank Rhame; Nicholaos Bellos; Jane Garb

• Book ID: 119253948
• Publisher: Termedia Sp. z.o.o.
• Year: 2012
• Tongue: English
• Weight: 346 KB
• Volume: 11
• Category: Article
• ISSN: 1730-1270
• DOI: 10.1016/j.hivar.2012.10.001